Mayo Clinic, Rochester, Minnesota, USA.
Qual Health Res. 2019 Oct;29(12):1823-1835. doi: 10.1177/1049732319846867. Epub 2019 May 5.
The application of gene editing technologies to prevent or mitigate genetic disease in humans is considered one of its most promising applications. However, as the technology advances, it is imperative to understand the views of the broader public on how it should be used. We conducted focus groups to understand public views on the ethical permissibility and governance of gene editing technologies in humans. A total of 50 urban and semirural residents in the upper Midwest took part in six focus groups. Participants expressed multiple concerns about nonmedical uses of gene editing and its potential for unknown harms to human health, and were divided as to whether the individual patient or "medical experts" should be charged with overseeing the scope of its application. As potential stakeholders, the perspectives from the general public are critical to assess as genome editing technologies advance toward the clinic.
基因编辑技术在预防或减轻人类遗传疾病方面的应用被认为是其最有前途的应用之一。然而,随着技术的进步,了解更广泛的公众对其应用方式的看法是至关重要的。我们进行了焦点小组讨论,以了解公众对人类基因编辑技术的伦理可允许性和治理的看法。中西部上半区共有 50 名城市和半农村居民参加了六个焦点小组。参与者对基因编辑的非医疗用途及其对人类健康造成未知危害的可能性表示了多种担忧,并对个体患者或“医学专家”是否应该负责监督其应用范围存在分歧。作为潜在的利益相关者,在基因组编辑技术向临床推进的过程中,从普通公众的角度进行评估是至关重要的。